Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study explores outcomes of canine MVR surgery
Cavalier King Charles Spaniels are particularly susceptible to MMVD.

RVC investigated the benefits of a structured multidisciplinary approach.

A new study has explored how a structured approach to surgery could improve outcomes of myxomatous mitral valve disease (MMVD).

MMVD is the most common heart disease in dogs, affecting 3.5 per cent of canine population in the UK. Its progression can be unpredictable, but many dogs will develop fatal heart failure.

The disease is usually treated through open heart surgery – a procedure which is in its infancy with dogs. Mitral valve repair (MVR) surgery is currently only performed in specialist centres, including the Royal Veterinary College (RVC) Queen Mother Hospital for Animals.

Research has been conducted over the past few years, reaching a consensus that MVR surgery is an effective solution for many dogs.

This has included a canine MVR capability study, which a specialist RVC team has been undertaking since 2015. Led by Daniel Brockman, the team developed an approach and procedure for MVR for suitable candidates.

The clinical team recorded the mitral valve repairs they performed on 132 dogs between July 2015 and November 2022.

This data included a description of the standard practices of the team and the population of the dogs – including breed, age, gender and clinical condition. It also reported the short-term outcomes of the procedure, as well as any trends in causes or suspected causes of mortality, as it sought to understand any links between ‘technical’ and ‘disease’ factors.

There was a consistent trend of improved outcomes, with 30 of the last 33 dogs recovering from the procedure. Throughout the study period, 107 of the 132 dogs survived to discharge from the hospital.

The results suggest that any team performing MVR must have a high level of individual expertise. They must also have a high level of co-ordination and communication to make decisions and perform the procedure.

Researchers say that this co-ordination and communication is vital to reach agreements on suitable surgical candidates. Their individual expertise is also key to their competence with the technical aspects of a cardiopulmonary bypass (CPB) and their familiarity with relevant preoperative and intraoperative assessments.

Teams will also need to be competent with anesthetising dogs, understand the critical transition CPB and meet the postoperative requirements of dogs recovering from the story.

Prof Brockman, professor of small animal surgery at the RVC, said: “This manuscript represents the analysis of team performance in a complex sociotechnical environment.

“The results highlight the importance of team-working habits that include reflective and deliberate practice both by individuals and by the whole team delivering such a complex therapy.”

The full study can be found in the journal Veterinary Surgery.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.